Delivery Order SPE2DB25D7068-SPE2DB25FTWUT
Award Date
5/20/25
Potential Completion Date
5/21/25
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,852.90, is for the supply of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product. The contract has a period of performance through October 5, 2023 and is structured as a firm fixed-price delivery order. The contract is not designated as a set-aside....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,235.75, is for the delivery of MICROGESTIN FE 1-20 TABLET 28S. The contract has an ultimate completion date of April 10, 2024 and a firm fixed price pricing type. This contract award is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization, is the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,503.92 firm fixed-price contract is for the supply of the medication Microgestin Fe 1-20 Tablet 28s. The contract has an ultimate completion date of December 28, 2022 and is not designated as a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the for-profit organization Cencora, Inc., doing business as AmerisourceBergen. The $1,361.76 order is for the supply of MICROGESTIN FE 1.5-30 TAB 28S pharmaceutical products, with a completion date of January 26, 2024. The contract does not have a set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on a larger indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,557.38 firm fixed price delivery order is for the supply of MICROGESTIN FE 1.5-30 TAB 28S, a prescription medication. The award has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
This federal contract award is for the delivery of MICROGESTIN FE 1-20 TABLET 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,288.48 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on November 16, 2021, with a completion date of November 17, 2021. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Microgestin FE 1.5-30 tablets. The Firm Fixed Price contract, valued at $4,163.41, has an ultimate completion date of January 26, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical division. The IDC, valued at...
This federal contract award, with ID SPE2DB20D2104|SPE2DB23FT28T, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,325.94 firm fixed-price delivery order is for the supply of MICROGESTIN FE 1-20 TABLET 28S, with a completion date of May 1, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This contract award is for the delivery of Microgestin FE 1.5-30 tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $2,729.16 and an Ultimate Completion Date of December 18, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a larger Indefinite...
This federal contract award, valued at $1,489.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4554834923 - MICROGESTIN FE 1-20 TABLET 28S. The contract is a firm fixed-price delivery order with a completion date of September 21, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical for a...